SAFER, MORE EFFECTIVE REDUCES AGITATION HELPS PAIN AND WEIGHT GAIN MAY PROTECT THE BRAIN BETTER QUALITY OF LIFE FOR PATIENTS…
Tumor growth “remarkably slower” and tumor size “significantly smaller” Stomach-cancer cells in mice died off when treated with CBD. Human…
First of its kind in North America, and possibly the world The first substantial clinical trial to examine the effects…
Could one day help cure renal disease by activating CB2 receptors in the kidney Synthetic cannabinoid JWH-133 may be “a…
Massive potential of yet-to-be discovered compounds The number of plant terpenoids that could potentially hold therapeutic value is massive and…
GW Pharmaceuticals plans to recruit approximately 116 children with Lennox-Gastaut Syndrome to participate in a new clinical trial. The study…
Most recent patent granted on Oct. 24, 2019 Over the past two decades, GW Pharmaceuticals (GWPH) has been granted multiple…
Clinical trial currently underway since approximately November 27, 2019 Approximately 75 participants Study initiated in 2010 and recruiting since May…
A clinical trial to test the effects of THC on pain is underway at Yale University.
The study is one of 26 at Yale that are specific to cannabinoids.
Four new studies on CBD and clobazam have conflicting results.
Longstanding pain in a horse was relieved with CBD, according to a clinical commentary published in Equine Veterinary Education.
New treatments to manage diarrhea constipation and chronic abdominal pain are desperately needed.
Future treatment may include cannabinoids, according to a Mayo Clinic gastroenterologist.
In a new study published this week, scientists describe their discovery that: “The combination of CBD and clobazam produced an anticonvulsant effect against hyperthermia‐induced seizures (in mouse) that was greater than that observed with either CBD or clobazam alone.”
U.K. man diagnosed with lung cancer that was spreading to his lymph nodes had almost no evidence of cancer 14 months after taking CBD oil, according to physicians who first saw him in September 2016.
CBD is an “attractive candidate” for helping treat a highly aggressive cancer that is resistant to chemotherapy and has a high rate of relapse, says a new study published this week in Cell Death and Disease.
King’s College London, one of the top 25 universities in the world, is teaming up with Parkinson’s UK for a £1.2-million clinical trial to determine the safety and efficacy of CBD in treating Parkinson’s-related psychosis, characterized by hallucinations and delusions.
The clinical trial will determine, for the first time, whether CBD can correct the abnormal functioning of the brain that is causing symptoms such as hallucinations and delusions.
Inhaling cannabis makes for easier breathing, because it dilates – or opens up – the airways in the lungs, according to a 1973 study published in New England Journal of Medicine.
Various cancer cells respond differently to the same cannabis extracts, according to a nee study from Israel.
New clinical trial to assess the safety of CBD in patients with heart failure.
The evidence that cannabis works for pain is “so extensive,” says Dr. Russo.
It is also robust enough (for cannabis) by the National Academies of Sciences, Engineering and Medicine.
An 81-year-old woman with advanced ovarian cancer was symptom-free after 20 months of treatment that included CBD.
Provides the first real world data (outside a clinical trial) on the dosing of THC:CBD in amyotrophic lateral sclerosis (ALS).
Some bacterial infections are becoming resistant to antibiotics. It turns out that CBD may be effective in the fight against dangerous infections.
CBD is being credited for improving the quality of life and possibly extending it for two patients diagnosed with a deadly form of brain cancer.
Terpenes’ contribution to therapeutic effect of cannabinoids “may be significant.”
Mayo Clinic looks at effect of CBD on malfunctioning stomach muscles and/or or nerves.
Synthetic THC combiner Obsessive Compulsive Disorder: A marked reduction in symptoms, according to new research out of the New York State Psychiatric Institute.
Diseases of the gastrointestinal system, including cancer, are linked to the endocannabinoid system in humans, say researchers from Austria and Germany.
Experimental research out of Brazil found that cannabinoids may be able to halt the growth and spread of glioblastoma, an aggressive and incurable form of brain cancer.
Cannabis treatment significantly improved challenging behaviours in children suffering Autism Spectrum Disorder (ASD), says a new study done in Israel and published in the March issue of Journal of Autism Developmental Disorders.
For the first time, a clinical study has identified how CBD alters brain function in ways that may correlate with improvements in…
New research out of Los Angeles found that men who have sex with men and also use cannabis, but no other mind-altering drugs, had significantly fewer sexually transmitted infections, including HIV
Several studies on cannabis dependance & withdrawal, registered and completed as far back as 2013, were updated yesterday and today. Updated records show Jan 14 or 15 as last date the clinical trial met “Quality Control” criteria.
Aurora sponsors cancer-pain study featuring MedReleaf capsules.
Approximately 60 patients suffering breakthrough cancer pain to participate in clinical trial that compares fentanyl with inhaled medical cannabis.
Canaccord Genuity Growth Corp. complete reverse merger
Approximately 136 US military veterans in the San Diego area will participate in a phase 2 clinical trial that will test the effects of CBD on Post-Traumatic-Stress Disorder.
GW Pharmaceuticals’ research and development for the therapeutic use of cannabinoids dates back at least two decades.
Aphria’s Australian-based partner Althea granted Manufacture Licence by the Australian Government’s Office of Drug Control.
Columbia University researchers hoping high-CBD, low-THC strain of cannabis will be well tolerated in patients with aggressive form of brain cancer, #glioblastoma and decrease radiation-induced toxicities and nausea and other symptoms.
Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..
“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.”
@TetraBioPharma today announced a new CBD supply agreement with Alberta-based True North Cannabis.
True North will supply Tetra with high-quality, competitively priced CBD
Link btwn cannabis and glaucoma known for 25 yrs.
Human-eye cells studied under the microscope showed a a retina filled with “quite significant” cannabinoid receptors, according to scientists from the…
“The literature is nearly unanimous in suggesting that cannabinoids and endocannabinoids reduce the progression of cancer in preclinical model systems,”
CBD has beneficial effects in patients with schizophrenia and may represent a new class of treatment for the disorder.
THC produces opposite effects in the brain compared with CBD, according to Australian researchers who reviewed 31 scientific papers on the topic.
These changes are especially pronounced in brain regions that are rich in cannabinoid receptors, according to the study.
Reducing bone erosion in Rheumatoid Arthritis by using the body’s own endocannabinoid system
Anandamide activates the body’s cannabinoid receptors by bonding to them.